Choriogonadotropin alfa

绒促性素α

Report date: 2022/01/17 12:14:22

Base Information

Drug NameChoriogonadotropin alfa
Drug Alias NameRecombinant human chorionic gonadotropin绒膜促性腺激素α重组人绒促性素Choriogonadotropinum alfaChoriogonadotropin alpha +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonistsOvarian follicle stimulants
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsInfertility, FemaleAnovulationInfertility +[5] 
Global Approved IndicationsInfertility, FemaleAnovulationInfertility
Approved Indications in ChinaInfertility
Original Approved Country/TerritoryUnited States
Original Approved Date2000/09/20
Country/TerritoryUnited StatesSwitzerlandBrazil +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesEmd Serono IncMerck Europe BvSports Medicine Research And Testing Laboratory +[5] 
Inactive CompaniesIbsa Institut Biochimique SaFerring BvUniversity Of California San Diego +[4] 
Active IndicationsInfertility, FemaleAnovulationInfertility
Inactive IndicationsHypothalamic DiseasesPolycystic Ovary Syndrome

Other Information

ATC CodeG03GA08
Related LinksWikipediaDrugBankKEGG